CHANSON INTERNATIONAL HOLD-A (CHSN)
KYG2104U1076 - Common Stock
Overall CHSN gets a fundamental rating of 1 out of 10. We evaluated CHSN against 42 industry peers in the Consumer Staples Distribution & Retail industry. CHSN may be in some trouble as it scores bad on both profitability and health. CHSN does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
In the past year CHSN has reported negative net income.
CHSN had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CHSN reported negative net income in multiple years.
Of the past 5 years CHSN 4 years had a positive operating cash flow.
1.2 Ratios
CHSN has a worse Return On Assets (-0.59%) than 68.29% of its industry peers.
CHSN's Return On Equity of -1.89% is on the low side compared to the rest of the industry. CHSN is outperformed by 68.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.59% | ||
| ROE | -1.89% | ||
| ROIC | N/A |
ROA(3y)-0.86%
ROA(5y)0.42%
ROE(3y)-30.34%
ROE(5y)-11.26%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
In the last couple of years the Profit Margin of CHSN has declined.
CHSN has a Gross Margin of 43.43%. This is amongst the best in the industry. CHSN outperforms 92.68% of its industry peers.
In the last couple of years the Gross Margin of CHSN has remained more or less at the same level.
CHSN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 43.43% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y-50.2%
GM growth 3Y-1.85%
GM growth 5Y-0.97%
2. Health
2.1 Basic Checks
CHSN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CHSN has been increased compared to 1 year ago.
CHSN has more shares outstanding than it did 5 years ago.
CHSN has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 3.64 indicates that CHSN is not in any danger for bankruptcy at the moment.
CHSN has a Altman-Z score (3.64) which is comparable to the rest of the industry.
CHSN has a Debt/Equity ratio of 0.26. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.26, CHSN is doing good in the industry, outperforming 68.29% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 3.64 |
ROIC/WACCN/A
WACC7.48%
2.3 Liquidity
CHSN has a Current Ratio of 0.71. This is a bad value and indicates that CHSN is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.71, CHSN is doing worse than 85.37% of the companies in the same industry.
A Quick Ratio of 0.66 indicates that CHSN may have some problems paying its short term obligations.
CHSN's Quick ratio of 0.66 is in line compared to the rest of the industry. CHSN outperforms 58.54% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.71 | ||
| Quick Ratio | 0.66 |
3. Growth
3.1 Past
CHSN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 84.23%, which is quite impressive.
CHSN shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -45.41% yearly.
The Revenue for CHSN has decreased by -27.62% in the past year. This is quite bad
CHSN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.60% yearly.
EPS 1Y (TTM)84.23%
EPS 3YN/A
EPS 5Y-45.41%
EPS Q2Q%-92.96%
Revenue 1Y (TTM)-27.62%
Revenue growth 3Y18.72%
Revenue growth 5Y7.6%
Sales Q2Q%-14.4%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
CHSN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
CHSN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
CHANSON INTERNATIONAL HOLD-A
NASDAQ:CHSN (11/22/2024, 8:00:00 PM)
After market: 7.32 -0.18 (-2.4%)7.5
+0.3 (+4.17%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap160.57M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.59% | ||
| ROE | -1.89% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 43.43% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.41
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 0.71 | ||
| Quick Ratio | 0.66 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)84.23%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-27.62%
Revenue growth 3Y18.72%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y